+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Ulcerative Colitis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • PDF Icon

    Report

  • 99 Pages
  • February 2024
  • Region: Global
  • Prof Research
  • ID: 5891627

Quick Summary:

In the highly competitive and rapidly evolving pharmaceutical industry, comprehensive and accurate market intelligence is an invaluable tool. Critical business decisions such as entry, investment, and expansion in the global Ulcerative Colitis Drug market demand insight that is both wide-ranging and specific. Our report offers exactly this - a thorough analysis of the competitive landscape, market dynamics, major players, and future trends.

Focusing on crucial regions such as North America, South America, Asia and Pacific, Europe, as well as MEA, this report gives you a granular view of supply, demand, and pricing trends from 2018 to 2028. It also presents a detailed profile of key players in the global Ulcerative Colitis Drug market, including SWOT analysis, sales volume, revenue, price, gross margin, and market share. Ensure your strategic maneuvers in this competitive landscape are backed by precise, timely, and comprehensive data. Dive into a nuanced understanding of this market, segmented by applications - hospitals, drug stores among others, and types - oral and injection.

This report describes the global market size of Ulcerative Colitis Drug from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Ulcerative Colitis Drug as well as some small players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Types Segment

  • Aminosalicylates
  • Corticosteroids
  • Immunomodulators
  • Targeted Synthetic Small Molecules
  • Biologic/Biosimilar

Companies Covered

  • AbbVie Inc.
  • AstraZeneca PLC
  • Bristol -Myers Squibb Co.
  • Eli Lilly
  • Gilead Sciences Inc.
  • Janssen Biotech Inc.
  • Johnson & Johnson
  • Pfizer Inc.
  • Merck & Co. Inc.
  • Millennium Pharmaceuticals Inc.
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Ulcerative Colitis Drug Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Ulcerative Colitis Drug Market in North America (2019-2029)
8.1 Ulcerative Colitis Drug Market Size
8.2 Ulcerative Colitis Drug Market by End Use
8.3 Competition by Players/Suppliers
8.4 Ulcerative Colitis Drug Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Ulcerative Colitis Drug Market in South America (2019-2029)
9.1 Ulcerative Colitis Drug Market Size
9.2 Ulcerative Colitis Drug Market by End Use
9.3 Competition by Players/Suppliers
9.4 Ulcerative Colitis Drug Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Ulcerative Colitis Drug Market in Asia & Pacific (2019-2029)
10.1 Ulcerative Colitis Drug Market Size
10.2 Ulcerative Colitis Drug Market by End Use
10.3 Competition by Players/Suppliers
10.4 Ulcerative Colitis Drug Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Ulcerative Colitis Drug Market in Europe (2019-2029)
11.1 Ulcerative Colitis Drug Market Size
11.2 Ulcerative Colitis Drug Market by End Use
11.3 Competition by Players/Suppliers
11.4 Ulcerative Colitis Drug Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Ulcerative Colitis Drug Market in MEA (2019-2029)
12.1 Ulcerative Colitis Drug Market Size
12.2 Ulcerative Colitis Drug Market by End Use
12.3 Competition by Players/Suppliers
12.4 Ulcerative Colitis Drug Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Ulcerative Colitis Drug Market (2019-2024)
13.1 Ulcerative Colitis Drug Market Size
13.2 Ulcerative Colitis Drug Market by End Use
13.3 Competition by Players/Suppliers
13.4 Ulcerative Colitis Drug Market Size by Type
Chapter 14 Global Ulcerative Colitis Drug Market Forecast (2024-2029)
14.1 Ulcerative Colitis Drug Market Size Forecast
14.2 Ulcerative Colitis Drug Application Forecast
14.3 Competition by Players/Suppliers
14.4 Ulcerative Colitis Drug Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 AbbVie Inc.
15.1.1 Company Profile
15.1.2 Main Business and Ulcerative Colitis Drug Information
15.1.3 SWOT Analysis of AbbVie Inc.
215.1.4 AbbVie Inc. Ulcerative Colitis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.2 AstraZeneca PLC
15.2.1 Company Profile
15.2.2 Main Business and Ulcerative Colitis Drug Information
15.2.3 SWOT Analysis of AstraZeneca PLC
215.2.4 AstraZeneca PLC Ulcerative Colitis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.3 Bristol -Myers Squibb Co.
15.3.1 Company Profile
15.3.2 Main Business and Ulcerative Colitis Drug Information
15.3.3 SWOT Analysis of Bristol -Myers Squibb Co.
215.3.4 Bristol -Myers Squibb Co. Ulcerative Colitis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.4 Eli Lilly
15.4.1 Company Profile
15.4.2 Main Business and Ulcerative Colitis Drug Information
15.4.3 SWOT Analysis of Eli Lilly
215.4.4 Eli Lilly Ulcerative Colitis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.5 Gilead Sciences Inc.
15.5.1 Company Profile
15.5.2 Main Business and Ulcerative Colitis Drug Information
15.5.3 SWOT Analysis of Gilead Sciences Inc.
215.5.4 Gilead Sciences Inc. Ulcerative Colitis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.6 Janssen Biotech Inc.
15.6.1 Company Profile
15.6.2 Main Business and Ulcerative Colitis Drug Information
15.6.3 SWOT Analysis of Janssen Biotech Inc.
215.6.4 Janssen Biotech Inc. Ulcerative Colitis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.7 Johnson & Johnson
15.7.1 Company Profile
15.7.2 Main Business and Ulcerative Colitis Drug Information
15.7.3 SWOT Analysis of Johnson & Johnson
215.7.4 Johnson & Johnson Ulcerative Colitis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.8 Pfizer Inc.
15.8.1 Company Profile
15.8.2 Main Business and Ulcerative Colitis Drug Information
15.8.3 SWOT Analysis of Pfizer Inc.
215.8.4 Pfizer Inc. Ulcerative Colitis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.9 Merck & Co. Inc.
15.9.1 Company Profile
15.9.2 Main Business and Ulcerative Colitis Drug Information
15.9.3 SWOT Analysis of Merck & Co. Inc.
215.9.4 Merck & Co. Inc. Ulcerative Colitis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.10 Millennium Pharmaceuticals Inc.
15.10.1 Company Profile
15.10.2 Main Business and Ulcerative Colitis Drug Information
15.10.3 SWOT Analysis of Millennium Pharmaceuticals Inc.
215.10.4 Millennium Pharmaceuticals Inc. Ulcerative Colitis Drug Revenue, Gross Margin and Market Share (2019-2024)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Ulcerative Colitis Drug Report
Table Data Sources of Ulcerative Colitis Drug Report
Table Major Assumptions of Ulcerative Colitis Drug Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Ulcerative Colitis Drug Picture
Table Ulcerative Colitis Drug Classification
Table Ulcerative Colitis Drug Applications
Table Drivers of Ulcerative Colitis Drug Market
Table Restraints of Ulcerative Colitis Drug Market
Table Opportunities of Ulcerative Colitis Drug Market
Table Threats of Ulcerative Colitis Drug Market
Table COVID-19 Impact For Ulcerative Colitis Drug Market
Table Raw Materials Suppliers
Table Different Production Methods of Ulcerative Colitis Drug
Table Cost Structure Analysis of Ulcerative Colitis Drug
Table Key End Users
Table Latest News of Ulcerative Colitis Drug Market
Table Merger and Acquisition
Table Planned/Future Project of Ulcerative Colitis Drug Market
Table Policy of Ulcerative Colitis Drug Market
Table 2019-2029 North America Ulcerative Colitis Drug Market Size
Figure 2019-2029 North America Ulcerative Colitis Drug Market Size and CAGR
Table 2019-2029 North America Ulcerative Colitis Drug Market Size by Application
Table 2019-2024 North America Ulcerative Colitis Drug Key Players Revenue
Table 2019-2024 North America Ulcerative Colitis Drug Key Players Market Share
Table 2019-2029 North America Ulcerative Colitis Drug Market Size by Type
Table 2019-2029 United States Ulcerative Colitis Drug Market Size
Table 2019-2029 Canada Ulcerative Colitis Drug Market Size
Table 2019-2029 Mexico Ulcerative Colitis Drug Market Size
Table 2019-2029 South America Ulcerative Colitis Drug Market Size
Figure 2019-2029 South America Ulcerative Colitis Drug Market Size and CAGR
Table 2019-2029 South America Ulcerative Colitis Drug Market Size by Application
Table 2019-2024 South America Ulcerative Colitis Drug Key Players Revenue
Table 2019-2024 South America Ulcerative Colitis Drug Key Players Market Share
Table 2019-2029 South America Ulcerative Colitis Drug Market Size by Type
Table 2019-2029 Brazil Ulcerative Colitis Drug Market Size
Table 2019-2029 Argentina Ulcerative Colitis Drug Market Size
Table 2019-2029 Chile Ulcerative Colitis Drug Market Size
Table 2019-2029 Peru Ulcerative Colitis Drug Market Size
Table 2019-2029 Asia & Pacific Ulcerative Colitis Drug Market Size
Figure 2019-2029 Asia & Pacific Ulcerative Colitis Drug Market Size and CAGR
Table 2019-2029 Asia & Pacific Ulcerative Colitis Drug Market Size by Application
Table 2019-2024 Asia & Pacific Ulcerative Colitis Drug Key Players Revenue
Table 2019-2024 Asia & Pacific Ulcerative Colitis Drug Key Players Market Share
Table 2019-2029 Asia & Pacific Ulcerative Colitis Drug Market Size by Type
Table 2019-2029 China Ulcerative Colitis Drug Market Size
Table 2019-2029 India Ulcerative Colitis Drug Market Size
Table 2019-2029 Japan Ulcerative Colitis Drug Market Size
Table 2019-2029 South Korea Ulcerative Colitis Drug Market Size
Table 2019-2029 Southeast Asia Ulcerative Colitis Drug Market Size
Table 2019-2029 Australia Ulcerative Colitis Drug Market Size
Table 2019-2029 Europe Ulcerative Colitis Drug Market Size
Figure 2019-2029 Europe Ulcerative Colitis Drug Market Size and CAGR
Table 2019-2029 Europe Ulcerative Colitis Drug Market Size by Application
Table 2019-2024 Europe Ulcerative Colitis Drug Key Players Revenue
Table 2019-2024 Europe Ulcerative Colitis Drug Key Players Market Share
Table 2019-2029 Europe Ulcerative Colitis Drug Market Size by Type
Table 2019-2029 Germany Ulcerative Colitis Drug Market Size
Table 2019-2029 France Ulcerative Colitis Drug Market Size
Table 2019-2029 United Kingdom Ulcerative Colitis Drug Market Size
Table 2019-2029 Italy Ulcerative Colitis Drug Market Size
Table 2019-2029 Spain Ulcerative Colitis Drug Market Size
Table 2019-2029 Belgium Ulcerative Colitis Drug Market Size
Table 2019-2029 Netherlands Ulcerative Colitis Drug Market Size
Table 2019-2029 Austria Ulcerative Colitis Drug Market Size
Table 2019-2029 Poland Ulcerative Colitis Drug Market Size
Table 2019-2029 Russia Ulcerative Colitis Drug Market Size
Table 2019-2029 MEA Ulcerative Colitis Drug Market Size
Figure 2019-2029 MEA Ulcerative Colitis Drug Market Size and CAGR
Table 2019-2029 MEA Ulcerative Colitis Drug Market Size by Application
Table 2019-2024 MEA Ulcerative Colitis Drug Key Players Revenue
Table 2019-2024 MEA Ulcerative Colitis Drug Key Players Market Share
Table 2019-2029 MEA Ulcerative Colitis Drug Market Size by Type
Table 2019-2029 Egypt Ulcerative Colitis Drug Market Size
Table 2019-2029 Israel Ulcerative Colitis Drug Market Size
Table 2019-2029 South Africa Ulcerative Colitis Drug Market Size
Table 2019-2029 Gulf Cooperation Council Countries Ulcerative Colitis Drug Market Size
Table 2019-2029 Turkey Ulcerative Colitis Drug Market Size
Table 2019-2024 Global Ulcerative Colitis Drug Market Size by Region
Table 2019-2024 Global Ulcerative Colitis Drug Market Size Share by Region
Table 2019-2024 Global Ulcerative Colitis Drug Market Size by Application
Table 2019-2024 Global Ulcerative Colitis Drug Market Share by Application
Table 2019-2024 Global Ulcerative Colitis Drug Key Vendors Revenue
Figure 2019-2024 Global Ulcerative Colitis Drug Market Size and Growth Rate
Table 2019-2024 Global Ulcerative Colitis Drug Key Vendors Market Share
Table 2019-2024 Global Ulcerative Colitis Drug Market Size by Type
Table 2019-2024 Global Ulcerative Colitis Drug Market Share by Type
Table 2024-2029 Global Ulcerative Colitis Drug Market Size by Region
Table 2024-2029 Global Ulcerative Colitis Drug Market Size Share by Region
Table 2024-2029 Global Ulcerative Colitis Drug Market Size by Application
Table 2024-2029 Global Ulcerative Colitis Drug Market Share by Application
Table 2024-2029 Global Ulcerative Colitis Drug Key Vendors Revenue
Figure 2024-2029 Global Ulcerative Colitis Drug Market Size and Growth Rate
Table 2024-2029 Global Ulcerative Colitis Drug Key Vendors Market Share
Table 2024-2029 Global Ulcerative Colitis Drug Market Size by Type
Table 2024-2029 Ulcerative Colitis Drug Global Market Share by Type

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • AstraZeneca PLC
  • Bristol -Myers Squibb Co.
  • Eli Lilly
  • Gilead Sciences Inc.
  • Janssen Biotech Inc.
  • Johnson & Johnson
  • Pfizer Inc.
  • Merck & Co. Inc.
  • Millennium Pharmaceuticals Inc.
  • Protagonist Therapeutics Inc.
  • Roche
  • Takeda Pharmaceutical Co Ltd.

Methodology

Loading
LOADING...